Merck Millipore

Articles by Merck Millipore

Merck Millipore Launches Simplicon™ RNA Reprogramming Technology for Efficient Generation of Virus-Free iPSCs

by Merck Millipore

Merck Millipore, the Life Science division of Merck, today (June 17) launched Simplicon™ RNA Reprogramming Technology, which uses synthetic self-replicating RNA to create large numbers of human induced pluripotent stem cells (iPSCs) using a single transfection step. This efficient reprogramming of somatic cells is accomplished without viral intermediates or host genome integration, offering a more defined and safer system for iPSC generation.